BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sui J, Miao Y, Han J, Nan H, Shen B, Zhang X, Zhang Y, Wu Y, Wu W, Liu T, Xu S, Yang S, Yin L, Pu Y, Liang G. Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma. Cancer Med 2018. [PMID: 29761859 DOI: 10.1002/cam4.1541] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi J, Ma H, Wang H, Zhu W, Jiang S, Dou R, Yan B. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling. J Cell Biochem 2019;120:18378-87. [PMID: 31190356 DOI: 10.1002/jcb.29149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
2 Cui Z, Luo Z, Lin Z, Shi L, Hong Y, Yan C. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. J Gene Med 2019;21:e3083. [PMID: 30811764 DOI: 10.1002/jgm.3083] [Cited by in Crossref: 27] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
3 Tan A, Li Q, Chen L. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway. Arch Biochem Biophys 2019;661:196-202. [PMID: 30468709 DOI: 10.1016/j.abb.2018.11.020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
4 Zhao X, Bai Z, Li C, Sheng C, Li H. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks. Biomed Res Int 2020;2020:8765461. [PMID: 32382578 DOI: 10.1155/2020/8765461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu M, Ma T, Shi S, Xing J, Xi Y. Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma. Life (Basel) 2021;11:1312. [PMID: 34947843 DOI: 10.3390/life11121312] [Reference Citation Analysis]
6 Zhang M, Gao F, Yu X, Zhang Q, Sun Z, He Y, Guo W. LINC00261: a burgeoning long noncoding RNA related to cancer. Cancer Cell Int 2021;21:274. [PMID: 34022894 DOI: 10.1186/s12935-021-01988-8] [Reference Citation Analysis]
7 Ye J, Wu S, Pan S, Huang J, Ge L. Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis. Oncol Rep 2020;43:1451-66. [PMID: 32323856 DOI: 10.3892/or.2020.7528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ouyang D, Li R, Li Y, Zhu X. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma. Med Sci Monit 2019;25:7998-8010. [PMID: 31650984 DOI: 10.12659/MSM.915798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Sui J, Miao Y, Han J, Nan H, Shen B, Zhang X, Zhang Y, Wu Y, Wu W, Liu T, Xu S, Yang S, Yin L, Pu Y, Liang G. Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma. Cancer Med 2018. [PMID: 29761859 DOI: 10.1002/cam4.1541] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
10 Unfried JP, Fortes P. LncRNAs in HCV Infection and HCV-Related Liver Disease. Int J Mol Sci 2020;21:E2255. [PMID: 32214045 DOI: 10.3390/ijms21062255] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
11 Zhang R, Li Y, Liu X, Qin S, Guo B, Chang L, Huang L, Liu S. FOXO3a-mediated long non-coding RNA LINC00261 resists cardiomyocyte hypoxia/reoxygenation injury via targeting miR23b-3p/NRF2 axis. J Cell Mol Med 2020;24:8368-78. [PMID: 32558131 DOI: 10.1111/jcmm.15292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wang S, Zhang S. Systematic analyses of a novel circRNA-related miRNAs prognostic signature for Cervical Cancer. Genet Mol Biol 2022;45:e20210405. [PMID: 35766420 DOI: 10.1590/1678-4685-GMB-2021-0405] [Reference Citation Analysis]
13 Jiang Y, Shen X, Fasae MB, Zhi F, Chai L, Ou Y, Feng H, Liu S, Liu Y, Yang S. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma. Oxid Med Cell Longev 2021;2021:4044606. [PMID: 34697563 DOI: 10.1155/2021/4044606] [Reference Citation Analysis]
14 Wang L, Wang H, Chen J, Ye X. Linc00261 Inhibited High-Grade Serous Ovarian Cancer Progression through miR-552-ATG10-EMT Axis. Computational and Mathematical Methods in Medicine 2022;2022:1-13. [DOI: 10.1155/2022/9450353] [Reference Citation Analysis]
15 Ye J, Li H, Wei J, Luo Y, Liu H, Zhang J, Luo X. Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis. Asian Pac J Cancer Prev 2020;21:1787-95. [PMID: 32592379 DOI: 10.31557/APJCP.2020.21.6.1787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Huang Y, Xiang B, Liu Y, Wang Y, Kan H. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer Lett. 2018;437:56-66. [PMID: 30165194 DOI: 10.1016/j.canlet.2018.08.024] [Cited by in Crossref: 67] [Cited by in F6Publishing: 79] [Article Influence: 16.8] [Reference Citation Analysis]
17 Wang Z, Zhang J, Yang B, Li R, Jin L, Wang Z, Yu H, Liu C, Mao Y, You Q. Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis. J Cancer 2019;10:6414-21. [PMID: 31772674 DOI: 10.7150/jca.32251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang A, Lei J. Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis. Medicine (Baltimore) 2021;100:e23749. [PMID: 33592832 DOI: 10.1097/MD.0000000000023749] [Reference Citation Analysis]
19 Chen W, Jiang J, Wang PP, Gong L, Chen J, Du W, Bi K, Diao H. Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network. DNA Cell Biol 2019;38:1112-24. [PMID: 31464520 DOI: 10.1089/dna.2019.4869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
20 Liu Y, Geng X. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis. Bioengineered 2022;13:3666-79. [PMID: 35081873 DOI: 10.1080/21655979.2021.2024328] [Reference Citation Analysis]
21 Li YX, Liu T, Liang YW, Huang JJ, Huang JS, Liu XG, Cheng ZY, Lu SX, Li M, Huang L. Integrative analysis of long non-coding RNA and messenger RNA expression in toll-like receptor 4-primed mesenchymal stem cells of ankylosing spondylitis. Ann Transl Med 2021;9:1563. [PMID: 34790769 DOI: 10.21037/atm-21-5020] [Reference Citation Analysis]
22 Zhang Z, Ouyang Y, Huang Y, Wang P, Li J, He T, Liu Q. Comprehensive bioinformatics analysis reveals potential lncRNA biomarkers for overall survival in patients with hepatocellular carcinoma: an on-line individual risk calculator based on TCGA cohort. Cancer Cell Int 2019;19:174. [PMID: 31312112 DOI: 10.1186/s12935-019-0890-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]